Avalere Health
An Inovalon Company
Insights Article

Advancing Oncology Care Quality in the Era of Immuno-oncology and Other Evolving Treatments

Eleanor Fitall | Jan 26, 2017

In June 2016, Avalere in collaboration with the American Society of Clinical Oncology, Cancer Support Community, Community Oncology Alliance, and Patient Advocate Foundation, and with support from Bristol-Myers Squibb, brought together a variety of healthcare stakeholders in a national Dialogue to discuss challenges and opportunities surrounding the advancement of quality in cancer care.

The objectives of the Dialogue were three-fold:

  1. Gain consensus on gaps in current cancer and the need for advancing cancer care in the era of immuno-oncology and other emerging treatments
  2. Discuss potential quality measure topics and what may be prioritized
  3. Determine a set of consensus-based recommendations to advance quality of care

Download the full report for the findings. 

Back to Results
« Back to Mobile Site